Alsinova
Alsinova drives medical innovation by supporting expert-led projects that push boundaries for better patient care. AI is integrated only when it enhances human expertise. Working directly in consultation spaces, Alsinova ensures impactful, real-world solutions.
Our capabilities
Life sciences
Rep quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora
R&D
Rep quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora
Data
Rep quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora
Our Services
- Clinical Strategy
- Operationalize clinical development
- Master RWE Projects
- Empower Data Science
- Lead Digital Innovation
Ensuring a successful clinical trial is key: from the clinical and regulatory strategy to elaborating the synopsis and to finalizing protocol, Alsinova is your sparring partner in supporting and challenging the design of your study. By bringing extensive experience, Alsinova can help you cover and assess the necessary steps to a robust clinical design.
Clinical research, and its inherent complexity and regulatory context, requires strict compliance with procedures to ensure the quality of trials. Alsinova surrounds you with experience and know-how to secure the end-to-end success of your clinical projects. Thanks to an approach based on expertise, agility, data and innovation, Alsinova offers all the services required for efficient management of your trials, without compromising on quality or on the schedule, and always within the budget.
Perform evaluation on the efficiency or tolerance of your life science products with post-authorization studies leveraging ‘in real life’ data. Whether they are requested by health authorities, by the industrial’s own initiative, for therapeutic or epidemiological understanding, or compassionate use, our teams bring their deep Real World Evidences (RWE) & Late Phase expertise to accompany you from study design, through to the operational management, giving sense and value to collected data.
Alsinova turns machine learning and artificial intelligence in healthcare and clinical trials into a reality, unlocking the full potential of data, digital and wearable technologies to improve the efficiency and safety of drugs, devices and technologies. We orchestrate data, analytics and technologies to improve patients’ lives, to facilitate the development of precision therapeutics, in order to make clinical research more translational and explore predictive medicine.
Alsinova leverages technologies to accelerate patient recruitment, foster patient engagement and conduct hybrid or virtual trials, by connecting patients and clinical trial ecosystems through a digital backbone. We help you build the capabilities to enable patient-centric and location-independant experiences, and to develop your digital therapeutic strategy. Should you need to identify innovative digital solutions to support your product or service development in specific disease areas, we are always ready to explore new borders with you and our technological partners.
Business case
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas consectetur, elit vitae facilisis eleifend, ipsum elit lobortis eros, elementum porta mi felis ut massa. Suspendisse eleifend pharetra tortor rhoncus condimentum. Aliquam ac est vel purus posuere lacinia.
Innovation AND R&D
Following the enforcement of the new European medical device regulation (EU 2017/745 or ‘MDR’), our client had to ensure product compliance for its product portfolio, in order to be able to continue commercialize them.
Data & Biostatistics
Our client, a large pharmaceutical company operating notably in Oncology, Neurology and Rare Diseases, reached out to us in the context of an indication extension for one of its flagship products.
Life Sciences
A Hearing Device sponsor needed Food & Drug Administration (FDA) approval to get their device on the US market. We had done a pilot study with the sponsor in conjunction with a CRO in France.
Data & Biostatistics
The client is a large pharmaceutical company operating in Oncology, Cardiology and the Generics fields. We have been working on all our delivery models: consulting, service platforms (FSP) and Projects.
Data & Biostatistics
Our client, a large pharmaceutical company operating notably in Oncology, Neurology and Rare Diseases, reached out to us in the context of an indication extension for one of its flagship products.
Lorem ipsum dolor sit amet
Would you like to work with us or have an idea for a project? We’d love to hear from you!
Career
Passionate about science and naturally curious, the team at Alsinova delivers exceptional quality work while embodying the values of our company in everything they do. Want to help shape the future by making health data matter? Apply today!
Our implantation
Contact
If you are a client click here :
If you are a candidate click here :